makevur.blogg.se - Vray licenses

Your healthcare provider should check your blood sugar before or soon after starting VRAYLAR and regularly during treatment. Extremely high blood sugar can lead to coma or death. High blood sugar and diabetes:Increases in blood sugar can happen in some people who take VRAYLAR.Problems with your metabolism, such as:.Your healthcare provider should monitor you for side effects for several weeks after starting or increasing dose of VRAYLAR. Some side effects may not happen right away and can start a few weeks after starting VRAYLAR, or if your dose increases.

Late-occurring side effects:VRAYLAR stays in your body for a long time.

Tardive dyskinesia may also start after you stop taking VRAYLAR. Tardive dyskinesia may not go away, even if you stop taking VRAYLAR.

Uncontrolled body movements (tardive dyskinesia or TD):VRAYLAR may cause movements that you cannot control in your face, tongue, or other body parts.

VRAYLAR should be stopped if you have NMS. These can be symptoms of a rare but potentially fatal side effect called NMS.

Neuroleptic malignant syndrome (NMS): Call your healthcare provider or go to the nearest hospital emergency room right away if you have high fever, stiff muscles, confusion, increased sweating, or changes in breathing, heart rate, and blood pressure.

Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death.

VRAYLAR may cause serious side effects, including: Report any change in these symptoms immediately to the doctor.

This is very important when VRAYLAR or the antidepressant is started or when the dose is changed. Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. Depression and other mental illnesses are the most important causes of suicidal thoughts and actions. VRAYLAR and antidepressants may increase suicidal thoughts or actions in some children and young adults especially within the first few months of treatment or when the dose is changed. VRAYLAR is not approved for treating patients with dementia-related psychosis. What is the most important information I should know about VRAYLAR?Įlderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death.